CS MURLIDHARAN
We will continue to see increase in share of revenues in speciality business: CS Murlidharan, Sun PharmaAs we have shared in the call the U.S. general pricing is more of product specific. We have not seen any specific changes in overall trends...- J Harinarayan seen leading race for IRDA top postJandhyala Harinarayan, an IAS officer of the 1970 batch, is said to have emerged the front-runner for the top slot at Insurance Regulatory ...
- Load More